Case Report
Ethambutol toxic optic neuropathy: A case report and review
Submitted: 22 August 2017 | Published: 17 May 2018
About the author(s)
Kevin C. Phillips, Department of Ophthalmic Sciences, Cape Peninsula University of Technology, South AfricaPeter C. Clarke-Farr, Department of Health & Wellness Sciences, Cape Peninsula University of Technology, South Africa
Abstract
This article presents a case of ethambutol toxic optic neuropathy determined during the routine optometric examination of a 66-year-old man. Ethambutol is an established drug for the treatment of tuberculosis, but has significant side effects, notably optic neuropathy. The prognosis for vision restoration is unpredictable, with the possibility of permanent vision loss. Treatment cessation is the only option to limit ocular damage; therefore, the early recognition of ethambutol optic neuropathy by optometrists is essential.
Keywords
Metrics
Total abstract views: 2944Total article views: 10513